Takeyoshi Yamashita
Chief Tech/Sci/R&D Officer presso KYOWA KIRIN CO. LTD.
Profilo
Takeyoshi Yamashita currently works at Kyowa Kirin Co., Ltd., as Director & Chief Medical Officer from 2023 and Orchard Therapeutics Plc, as Director from 2024.
Posizioni attive di Takeyoshi Yamashita
Società | Posizione | Inizio |
---|---|---|
KYOWA KIRIN CO. LTD. | Chief Tech/Sci/R&D Officer | 01/04/2023 |
ORCHARD THERAPEUTICS PLC | Director/Board Member | 24/01/2024 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
KYOWA KIRIN CO. LTD. | Health Technology |
Aziende private | 1 |
---|---|
Orchard Therapeutics Plc
Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Takeyoshi Yamashita